aTyr Pharma's market cap is currently $371.86M. The company's EPS TTM is $-0.936; its P/E ratio is ―; aTyr Pharma is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 353.00K	$ 10.39M	$ 0.00	$ 10.46M	$ 422.00K
Gross Profit	$ -2.39M	$ 8.69M	$ -1.30M	$ -6.84M	$ -13.63M
Operating Income	$ -54.92M	$ -46.40M	$ -34.02M	$ -15.91M	$ -22.98M
EBITDA	$ -52.18M	$ -44.71M	$ -32.47M	$ -14.64M	$ -21.61M
Net Income	$ -50.39M	$ -45.34M	$ -33.77M	$ -16.22M	$ -23.60M
Balance Sheet
Cash & Short-Term Investments	$ 98.17M	$ 66.15M	$ 107.91M	$ 31.69M	$ 31.14M
Total Assets	$ 120.65M	$ 95.79M	$ 115.54M	$ 38.73M	$ 36.19M
Total Debt	$ 15.10M	$ 11.53M	$ 1.38M	$ 2.24M	$ 11.73M
Net Debt	$ -7.45M	$ 1.55M	$ -958.00K	$ -14.71M	$ 2.52M
Total Liabilities	$ 30.18M	$ 24.50M	$ 6.41M	$ 7.24M	$ 15.16M
Stockholders' Equity	$ 90.66M	$ 71.46M	$ 109.30M	$ 31.65M	$ 21.19M
Cash Flow
Free Cash Flow	$ -37.44M	$ -43.53M	$ -33.27M	$ -15.50M	$ -20.09M
Operating Cash Flow	$ -33.22M	$ -41.89M	$ -33.08M	$ -15.30M	$ -20.01M
Investing Cash Flow	$ -20.13M	$ 47.24M	$ -91.57M	$ 6.90M	$ 4.92M
Financing Cash Flow	$ 66.23M	$ 5.45M	$ 110.03M	$ 16.14M	$ 1.34M

Currency in USD

aTyr Pharma Earnings and Revenue History

Income Statement >

aTyr Pharma Debt to Assets

Balance Sheet >

aTyr Pharma Cash Flow

Cash Flow >

aTyr Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing